These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38063155)

  • 21. Screening for Breast Cancer.
    Niell BL; Freer PE; Weinfurtner RJ; Arleo EK; Drukteinis JS
    Radiol Clin North Am; 2017 Nov; 55(6):1145-1162. PubMed ID: 28991557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer Risk Assessment Models and High-Risk Screening.
    Barke LD; Freivogel ME
    Radiol Clin North Am; 2017 May; 55(3):457-474. PubMed ID: 28411673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversy surrounding mammography screening? Not in our opinion.
    Drukteinis JS; Kiluk JV
    Cancer Control; 2014 Apr; 21(2):176-7. PubMed ID: 24667405
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    Johnson KJ; O'Connell CP; Waken RJ; Barnes JM
    PLoS One; 2024; 19(5):e0303280. PubMed ID: 38768115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technologists' Characteristics and Quality of Positioning in Daily Practice in a Canadian Breast Cancer Screening Program.
    Guertin MH; Théberge I; Zomahoun HT; Dufresne MP; Pelletier É; Brisson J
    Acad Radiol; 2016 Nov; 23(11):1359-1366. PubMed ID: 27567127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Developments in Breast Cancer Screening and Treatment.
    Dinardo D; McNeil M
    J Womens Health (Larchmt); 2019 Apr; 28(4):423-426. PubMed ID: 30969906
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
    Sprague BL; Nowak SA; Ahern TP; Herschorn SD; Kaufman PA; Odde C; Perry H; Sowden MM; Vacek PM; Weaver DL
    Radiol Imaging Cancer; 2024 May; 6(3):e230161. PubMed ID: 38578209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weighing the Benefits and Risks of Mammography Screening Strategies.
    Trentham-Dietz A;
    Radiology; 2024 Oct; 313(1):e240819. PubMed ID: 39352278
    [No Abstract]   [Full Text] [Related]  

  • 29. Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography.
    Kerlikowske K; Hubbard R; Tosteson AN
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031310
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence to Support Screening Women Annually.
    Eby PR
    Radiol Clin North Am; 2017 May; 55(3):441-456. PubMed ID: 28411672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients characteristics related to screening mammography cancellation and rescheduling rates during the COVID-19 pandemic.
    Amornsiripanitch N; Chikarmane SA; Bay CP; Giess CS
    Clin Imaging; 2021 Dec; 80():205-210. PubMed ID: 34340204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
    Vanni G; Pellicciaro M; Materazzo M; Bruno V; Oldani C; Pistolese CA; Buonomo C; Caspi J; Gualtieri P; Chiaravalloti A; Palombi L; Piccione E; Buonomo OC
    In Vivo; 2020; 34(5):3047-3053. PubMed ID: 32871851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The eternal problem of false positives in mammography screening].
    Seguí Díaz M
    Semergen; 2017 Mar; 43(2):151-153. PubMed ID: 27117788
    [No Abstract]   [Full Text] [Related]  

  • 34. Overweight women may require more frequent mammograms.
    Printz C
    Cancer; 2018 Mar; 124(6):1099. PubMed ID: 29509326
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database.
    Grimm LJ; Lee C; Rosenberg RD; Burleson J; Simanowith M; Fruscello T; Pelzl CE; Friedewald SM; Moy L; Zuley ML
    J Am Coll Radiol; 2022 Aug; 19(8):919-934. PubMed ID: 35690079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the COVID-19 pandemic on the volume of mammography examinations in Southern Taiwan.
    Chou CP; Pan HB; Yang TL; Chiang CL; Huang JS; Tsai MY
    Breast J; 2021 Jan; 27(1):89-91. PubMed ID: 32815587
    [No Abstract]   [Full Text] [Related]  

  • 37. Can digital breast tomosynthesis decrease interval cancers in a breast cancer screening program?
    Mullen LA
    Eur Radiol; 2024 Aug; 34(8):5425-5426. PubMed ID: 38319429
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening Contrast-enhanced Mammography: Assessment of Patient Experience.
    Fung-Lee S; Joe BN
    Radiol Imaging Cancer; 2024 Sep; 6(5):e249017. PubMed ID: 39177472
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors influencing breast density in Japanese women aged 40-49 in breast cancer screening mammography.
    Kawahara M; Sato S; Ida Y; Watanabe M; Fujishima M; Ishii H; Hori K; Kanazawa S
    Acta Med Okayama; 2013; 67(4):213-7. PubMed ID: 23970319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.
    Klarenbach S; Sims-Jones N; Lewin G; Singh H; Thériault G; Tonelli M; Doull M; Courage S; Garcia AJ; Thombs BD;
    CMAJ; 2018 Dec; 190(49):E1441-E1451. PubMed ID: 30530611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.